Skip to content
Screener

Cencora COR Total Revenue

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$22.97B+47.7%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$63.67B+5.8%
McKesson logo
McKessonMCK
$105.38B+7.7%
United Parcel Service, Inc. logo
United Parcel Service, Inc.UPS
$22.83B+7.6%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$48.97M+7.7%
AbbVie logo
AbbVieABBV
$16.99B+10.2%

Segments

By product

See full
Alliance Healthcare$6.6B+6.0%
Animal Health$1.52B+3.3%
Other Healthcare Solutions$1.08B+5.4%
Other non-strategic businesses$733.55M+15.4%

By segment

See full
U.S. Healthcare Solutions$74.86B+4.9%
International Healthcare Solutions$7.68B+5.9%

Other financials

Income statement

See full
Gross profit$3.6B+24.1%
Operating income$1.1B+29.1%
Net income$763.5M+11.1%
EPS (diluted)$3.94+11.9%

Balance sheet

See full
Cash & equivalents$2.8B+26.1%
Total debt$11.7B+45.7%
Total equity$3.1B+54.1%
Total assets$83.8B+13.3%

Cash flow

See full
Operating cash flow$2.7B+2,329%
CapEx$226.0M+23.4%
Free cash flow$2.4B

Valuation

See full
Market cap$62.55B+11.0%
Enterprise value$71.46B+15.0%
P/E17.1×+3.5×
P/S0.2×0.0×

Profitability

See full
Gross margin4%+0.5pp
Operating margin0.9%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.8×-0.2×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Cencora’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 3:23 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001140859-26-000034
(in thousands, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Nine months ended June 30, 2026Nine months ended June 30, 2025
Revenue$84,754,837$80,663,532$249,042,769$237,604,265
Cost of goods sold81,147,60277,756,417238,775,124229,079,303
Gross profit3,607,2352,907,11510,267,6458,524,962
Operating expenses:
Distribution, selling, and administrative2,132,4651,672,8815,905,3134,744,976
Depreciation150,960128,128417,384362,655
Amortization118,539125,867361,808429,650
Litigation and opioid-related (credit) expenses, net(88,643)17,974(160,936)46,263

ITEM 1. Financial Statements (Unaudited)

FAQ

What is Cencora's total revenue?
Cencora (COR) reported total revenue of $84.75B in Q2 2026.
How has Cencora's total revenue changed year-over-year?
Cencora's total revenue increased by 5.1% year-over-year, from $80.66B to $84.75B.
What is the long-term trend for Cencora's total revenue?
Over 4 years (2021 to 2025), Cencora's total revenue has grown at a 10.7% compound annual growth rate (CAGR), from $213.99B to $321.33B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Cencora's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude